Upstream Bio (UPB) Non-Current Assets (2023 - 2026)

Upstream Bio's Non-Current Assets history runs 4 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 25.48% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $8.2 million (down 22.64% YoY), while the FY2025 annual figure was $2.0 million, down 22.82% from the prior year.
• Non-Current Assets was $1.8 million for Q1 2026 at Upstream Bio, down from $2.0 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $5.4 million in Q3 2024 to a low of $202000.0 in Q4 2023.
• Historically, Non-Current Assets has averaged $2.3 million across 4 years, with a median of $2.2 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets jumped 1166.83% in 2024, then plunged 59.87% in 2025.
• A 4-year view of Non-Current Assets shows it stood at $202000.0 in 2023, then surged by 1166.83% to $2.6 million in 2024, then decreased by 22.82% to $2.0 million in 2025, then retreated by 10.13% to $1.8 million in 2026.
• The last three Non-Current Assets figures came in at $1.8 million (Q1 2026), $2.0 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.